{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:12:31Z","timestamp":1759936351973,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FI20\/00237","CM18\/00054"],"award-info":[{"award-number":["FI20\/00237","CM18\/00054"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010552","name":"Departament de Salut, Generalitat de Catalunya","doi-asserted-by":"publisher","award":["SLT008\/18\/00193"],"award-info":[{"award-number":["SLT008\/18\/00193"]}],"id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Interferon-gamma release assays performance can be impaired by host-related, technical and environmental factors, but data in young children are limited. We performed a cross-sectional study of children\u2009&lt;\u20095\u00a0years-of-age at risk of tuberculosis (TB), using QuantiFERON-TB Gold In-Tube (QFT-GIT) assays. The impact of the following was evaluated: (i) host-related [age; hematological parameters; erythrocyte sedimentation rate (ESR); C-reactive protein (CRP); and tobacco smoke exposure (TSE) based on serum cotinine concentrations], (ii) technical (pre-analytical delay) and (iii) environmental factors (annual season; monthly temperatures). Of 204 children, 35 (17.2%) were diagnosed with latent TB infection or TB disease. QFT-GIT results were indeterminate in 14 (6.9%) patients. In multivariate analysis, younger age and higher ESR were associated with lower positive control responses (beta: 0.247, <jats:italic>p<\/jats:italic>\u2009=\u20090.002 and \u2212\u00a00.204, <jats:italic>p<\/jats:italic>\u2009=\u20090.007, respectively), and increasing age was associated with lower rates of indeterminate QFT-GIT results [OR (95% CI) 0.948 (0.903\u20130.996) per month, <jats:italic>p<\/jats:italic>\u2009=\u20090.035]. In children with positive QFT-GIT results, average monthly temperatures correlated with antigen responses (r\u2009=\u20090.453, <jats:italic>p<\/jats:italic>\u2009=\u20090.020); also, antigen responses were lower in winter than in other seasons (<jats:italic>p<\/jats:italic>\u2009=\u20090.027). Serum cotinine concentrations determined in a subgroup of patients (n\u2009=\u200941) indicated TSE in 36 (88%), positive control responses being lower in children with TSE (<jats:italic>p<\/jats:italic>\u2009=\u20090.034). In children\u2009&lt;\u20095\u00a0years-of-age, young age, elevated ESR, temperature, annual season and TSE can affect the performance of QFT-GIT assays.<\/jats:p>","DOI":"10.1038\/s41598-022-24433-w","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T11:02:27Z","timestamp":1668855747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Host, technical, and environmental factors affecting QuantiFERON-TB Gold In-Tube performance in children below 5\u00a0years of age"],"prefix":"10.1038","volume":"12","author":[{"given":"Eneritz","family":"Velasco-Arnaiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Batllori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Monson\u00eds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Valls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"R\u00edos-Barnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00edlvia","family":"Sim\u00f3-Nebot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Gamell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e0udia","family":"Fortuny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Tebruegge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7485-0583","authenticated-orcid":false,"given":"Antoni","family":"Noguera-Julian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"key":"24433_CR1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1590\/s1806-37562017000000219","volume":"43","author":"M Amicosante","year":"2017","unstructured":"Amicosante, M. et al. Current use and acceptability of novel diagnostic tests for active tuberculosis: A worldwide survey. J. Bras. Pneumol. 43, 380\u2013392 (2017).","journal-title":"J. Bras. Pneumol."},{"key":"24433_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099129","volume":"9","author":"M Tebruegge","year":"2014","unstructured":"Tebruegge, M. et al. Availability and use of molecular microbiological and immunological tests for the diagnosis of tuberculosis in Europe. PLoS ONE 9, e99129 (2014).","journal-title":"PLoS ONE"},{"key":"24433_CR3","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1097\/INF.0000000000002015","volume":"37","author":"E Velasco-Arnaiz","year":"2017","unstructured":"Velasco-Arnaiz, E. et al. Performance of tuberculin skin tests and interferon-\u03b3 release assays in children younger than 5 years. Pediatr. Infect. Dis. J. 37, 1235\u20131241 (2017).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"24433_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/cid\/ciw778","volume":"64","author":"DM Lewinsohn","year":"2017","unstructured":"Lewinsohn, D. M. et al. Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for disease control and prevention clinical practice guidelines: Diagnosis of tuberculosis in adults and children. Clin. Infect. Dis. 64, 111\u2013115 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"24433_CR5","unstructured":"National Institute for Health and Clinical Excellence. Tuberculosis. NICE guideline. https:\/\/www.nice.org.uk\/guidance\/ng33 (2016)."},{"issue":"52","key":"24433_CR6","first-page":"e1","volume":"88","author":"MJ Mellado-Pe\u00f1a","year":"2018","unstructured":"Mellado-Pe\u00f1a, M. J. et al. Tuberculosis treatment for children: An update. An. Pediatr. (Barc.) 88(52), e1-52.e12 (2018).","journal-title":"An. Pediatr. (Barc.)"},{"key":"24433_CR7","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics. Tuberculosis. In Red Book: 2018 Report of the Committee on Infectious Diseases, 31st ed. (eds. Kimberlin, D. W., Brady, M. T., Jackson, M. A., Long, S. S.) 829\u2013853 (American Academy of Pediatrics, 2018).","DOI":"10.1542\/9781610021470-part03-tuberculosis"},{"key":"24433_CR8","unstructured":"Menzies, D. Canadian TB standards 7th edition. Canadian Thoracic Society, Canadian Lung Association and Public Health Agency of Canada. http:\/\/www.respiratoryguidelines.ca\/tbstandards-2013 (2014)."},{"key":"24433_CR9","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1097\/INF.0000000000002517","volume":"39","author":"E Velasco-Arnaiz","year":"2020","unstructured":"Velasco-Arnaiz, E. et al. Impact of baseline tuberculin skin test and isoniazid chemoprophylaxis on subsequent Quantiferon-TB Gold In-tube performance in young children assessed after tuberculosis contact in Catalonia. Pediatr. Infect. Dis. J. 39, e22\u2013e25 (2020).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"24433_CR10","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/INF.0b013e31819abf6b","volume":"28","author":"L Bianchi","year":"2009","unstructured":"Bianchi, L. et al. Interferon-gamma release assay improves the diagnosis of tuberculosis in children. Pediatr. Infect. Dis. J. 28, 510\u2013514 (2009).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"24433_CR11","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/INF.0b013e3181a16394","volume":"28","author":"T Haustein","year":"2009","unstructured":"Haustein, T. et al. The likelihood of an indeterminate test result froma whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr. Infect. Dis. J. 28, 669\u2013673 (2009).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"24433_CR12","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-3918","volume":"141","author":"AW Kay","year":"2018","unstructured":"Kay, A. W., Islam, S. M., Wendorf, K., Westenhouse, J. & Barry, P. M. Interferon-\u03b3 release assay performance for tuberculosis in childhood. Pediatrics 141, e20173918 (2018).","journal-title":"Pediatrics"},{"key":"24433_CR13","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1183\/09031936.00153408","volume":"33","author":"B Kampmann","year":"2009","unstructured":"Kampmann, B. et al. IFN-\u03b3 release assays do not identify more children with active tuberculosis than the tuberculin skin test. Eur. Respir. J. 33, 1374\u20131382 (2009).","journal-title":"Eur. Respir. J."},{"key":"24433_CR14","doi-asserted-by":"publisher","first-page":"17842","DOI":"10.1038\/s41598-017-17865-2","volume":"7","author":"ML Decker","year":"2017","unstructured":"Decker, M. L., Gotta, V., Wellmann, S. & Ritz, N. Cytokine profiling in healthy children shows association of age with cytokine concentrations. Sci. Rep. 7, 17842 (2017).","journal-title":"Sci. Rep."},{"key":"24433_CR15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3389\/fped.2017.00255","volume":"5","author":"ML Decker","year":"2017","unstructured":"Decker, M. L., Grobusch, M. P. & Ritz, N. Influence of age and other factors on cytokine expression profiles in healthy children\u2014A systematic review. Front. Pediatr. 5, 255 (2017).","journal-title":"Front. Pediatr."},{"key":"24433_CR16","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.4269\/ajtmh.18-0684","volume":"101","author":"MS Wang","year":"2019","unstructured":"Wang, M. S. & Liu, X. J. Risk factors for false-negative interferon-\u03b3 release assay results in culture-confirmed childhood TB. Am. J. Trop. Med. Hyg. 101, 1303\u20131307 (2019).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"24433_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fped.2019.00208","volume":"7","author":"NR Meier","year":"2019","unstructured":"Meier, N. R. et al. Risk factors for indeterminate interferon-gamma release assay for the diagnosis of tuberculosis in children-a systematic review and meta-analysis. Front. Pediatr. 7, 208 (2019).","journal-title":"Front. Pediatr."},{"key":"24433_CR18","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jinf.2015.04.004","volume":"71","author":"J Jarvis","year":"2015","unstructured":"Jarvis, J. et al. Environmental temperature impacts on the performance of QuantiFERON-TB Gold In-Tube assays. J. Infect. 71, 276\u2013280 (2015).","journal-title":"J. Infect."},{"key":"24433_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.tube.2018.03.002","volume":"110","author":"M Tebruegge","year":"2018","unstructured":"Tebruegge, M. et al. Seasonal variation in the performance of QuantiFERON-TB Gold In-Tube assays used for the diagnosis of tuberculosis infection. Tuberculosis (Edinb.) 110, 26\u201329 (2018).","journal-title":"Tuberculosis (Edinb.)"},{"key":"24433_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1465-9921-11-64","volume":"110","author":"MA Modestou","year":"2010","unstructured":"Modestou, M. A., Manzel, L. J., El-Mahdy, S. & Look, D. C. Inhibition of IFN-gamma dependent antiviral airway epithelial defense by cigarette smoke. Respir. Res. 110, 64 (2010).","journal-title":"Respir. Res."},{"key":"24433_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/1471-2334-12-379","volume":"12","author":"MG Aabye","year":"2012","unstructured":"Aabye, M. G. et al. Negative effect of smoking on the performance of the QuantiFERON TB gold in tube test. BMC Infect. Dis. 12, 379 (2012).","journal-title":"BMC Infect. Dis."},{"key":"24433_CR22","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1038\/srep03864","volume":"4","author":"X Xu","year":"2014","unstructured":"Xu, X., Su, Y. & Fan, Z. H. Cotinine concentration in serum correlates with tobacco smoke-induced emphysema in mice. Sci. Rep. 4, 3864 (2014).","journal-title":"Sci. Rep."},{"key":"24433_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11882-017-0723-0","volume":"17","author":"LD Makadia","year":"2017","unstructured":"Makadia, L. D., Roper, P. J., Andrews, J. O. & Tingen, M. S. Tobacco use and smoke exposure in children: New trends, harm, and strategies to improve health outcomes. Curr. Allergy. Asthma. Rep. 17, 55 (2017).","journal-title":"Curr. Allergy. Asthma. Rep."},{"key":"24433_CR24","doi-asserted-by":"publisher","first-page":"696","DOI":"10.2105\/AJPH.78.6.696","volume":"78","author":"MJ Jarvis","year":"1988","unstructured":"Jarvis, M. J., Russell, M. A. H., Benowitz, N. L. & Feyerabend, C. Elimination of cotinine from body fluids: Implications for noninvasive measurement of tobacco smoke exposure. Am. J. Public Health 78, 696\u2013698 (1988).","journal-title":"Am. J. Public Health"},{"key":"24433_CR25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/oxfordjournals.epirev.a017925","volume":"18","author":"NL Benowitz","year":"1996","unstructured":"Benowitz, N. L. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol. Rev. 18, 188\u2013204 (1996).","journal-title":"Epidemiol. Rev."},{"key":"24433_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/FTD.0b013e3181957a3b","volume":"31","author":"A Florescu","year":"2009","unstructured":"Florescu, A. et al. Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: Focus on developmental toxicology. Ther. Drug. Monit. 31, 14\u201330 (2009).","journal-title":"Ther. Drug. Monit."},{"key":"24433_CR27","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1128\/JCM.00814-14","volume":"52","author":"M Tebruegge","year":"2014","unstructured":"Tebruegge, M. et al. Extremes of age are associated with indeterminate QuantiFERON-TB gold assay results. J. Clin. Microbiol. 52, 2694\u20132697 (2014).","journal-title":"J. Clin. Microbiol."},{"key":"24433_CR28","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/INF.0b013e3181c4822f","volume":"29","author":"TG Connell","year":"2010","unstructured":"Connell, T. G. et al. Indeterminate interferon-gamma release assay results in children. Pediatr. Infect. Dis. J. 29, 285\u2013286 (2010).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"24433_CR29","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/MPG.0000000000000205","volume":"58","author":"O Hradsky","year":"2014","unstructured":"Hradsky, O. et al. Disease activity is an important factor for indeterminate interferon-\u03b3 release assay results in children with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 58, 320\u2013324 (2014).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"24433_CR30","doi-asserted-by":"crossref","unstructured":"Calzada-Hern\u00e1ndez, J., et al. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-\u03b1 inhibitor initiation in children in Spain. Eur. J. Pediatr. (2022) (published online ahead of print).","DOI":"10.1007\/s00431-022-04640-3"},{"key":"24433_CR31","doi-asserted-by":"crossref","unstructured":"Soler-Garcia, A., et al. Performance of QuantiFERON-TB Gold Plus assays in children and adolescents at risk of tuberculosis: A cross-sectional multicentre study. Thorax (2021) (published online ahead of print).","DOI":"10.1136\/thoraxjnl-2021-217592"},{"key":"24433_CR32","doi-asserted-by":"publisher","first-page":"7000","DOI":"10.1038\/ncomms8000","volume":"6","author":"XC Dopico","year":"2015","unstructured":"Dopico, X. C. et al. Widespread seasonal gene expression reveals annual differences in human immunity and physiology. Nat. Commun. 6, 7000 (2015).","journal-title":"Nat. Commun."},{"key":"24433_CR33","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/archpediatrics.2012.170","volume":"166","author":"DA Dempsey","year":"2012","unstructured":"Dempsey, D. A. et al. Determination of tobacco smoke exposure by plasma cotinine levels in infants and children attending urban public hospital clinics. Arch. Pediatr. Adolesc. Med. 166, 851\u2013856 (2012).","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"24433_CR34","first-page":"1049","volume":"11","author":"K Slama","year":"2007","unstructured":"Slama, K. et al. Tobacco and tuberculosis: A qualitative systematic review and metaanalysis. Int. J. Tuberc. Lung. Dis. 11, 1049\u20131061 (2007).","journal-title":"Int. J. Tuberc. Lung. Dis."},{"key":"24433_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1183\/09031936.00072909","volume":"35","author":"RN van Zyl-Smit","year":"2010","unstructured":"van Zyl-Smit, R. N. et al. Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD. Eur. Respir. J. 35, 27\u201333 (2010).","journal-title":"Eur. Respir. J."},{"key":"24433_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182998","volume":"12","author":"N Altet","year":"2017","unstructured":"Altet, N. et al. Assessment of the influence of direct tobacco smoke on infection and active TB management. PLoS\u00a0One 12, e0182998 (2017).","journal-title":"PLoS\u00a0One"},{"key":"24433_CR37","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1128\/JCM.00482-10","volume":"48","author":"V Herrera","year":"2010","unstructured":"Herrera, V., Yeh, E., Murphy, K., Parsonnet, J. & Banaei, N. Immediate incubation reduces indeterminate results for QuantiFERON-TB Gold in-tube assay. J. Clin. Microbiol. 48, 2672\u20132676 (2010).","journal-title":"J. Clin. Microbiol."},{"key":"24433_CR38","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1128\/JCM.01136-11","volume":"49","author":"D Doberne","year":"2011","unstructured":"Doberne, D., Gaur, R. L. & Banaei, N. Preanalytical delay reduces sensitivity of QuantiFERON-TB gold in-tube assay for detection of latent tuberculosis infection. J. Clin. Microbiol. 49, 3061\u20133064 (2011).","journal-title":"J. Clin. Microbiol."},{"key":"24433_CR39","doi-asserted-by":"publisher","first-page":"143.e1","DOI":"10.1016\/j.anpedi.2009.12.017","volume":"73","author":"D Moreno-P\u00e9rez","year":"2010","unstructured":"Moreno-P\u00e9rez, D. et al. Diagnosis of tuberculosis in pediatrics. Consensus document of the Spanish Society of Pediatric Infectology (SEIP) and the Spanish Society of Pediatric Pneumology (SENP). An. Pediatr. (Barc.) 73, 143.e1-143.14 (2010).","journal-title":"An. Pediatr. (Barc.)"},{"key":"24433_CR40","unstructured":"QuantiFERON\u00ae-TB Gold (In-Tube Method) Package Insert. Cellestis\/Qiagen, Australia. https:\/\/www.quantiferon.com\/wp-content\/uploads\/2019\/03\/L1075115-QuantiFERON-TB-Gold-ELISA-IFU-CE-rev07.pdf (2018)."},{"key":"24433_CR41","doi-asserted-by":"publisher","first-page":"3758068","DOI":"10.1155\/2018\/3758068","volume":"2018","author":"D Djordjevic","year":"2018","unstructured":"Djordjevic, D. et al. Neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume-to-platelet count ratio as biomarkers in critically ill and injured patients: Which ratio to choose to predict outcome and nature of bacteremia?. Mediat. Inflamm. 2018, 3758068 (2018).","journal-title":"Mediat. Inflamm."},{"key":"24433_CR42","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1186\/s12879-020-05331-w","volume":"20","author":"CA Rees","year":"2020","unstructured":"Rees, C. A. et al. The potential of CBC-derived ratios (monocyte-to-lymphocyte, neutrophil-to-lymphocyte, and platelet-to-lymphocyte) to predict or diagnose incident TB infection in Tanzanian adolescents. BMC Infect. Dis. 20, 609 (2020).","journal-title":"BMC Infect. Dis."},{"key":"24433_CR43","unstructured":"U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS. Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events, Corrected Version 2.1. https:\/\/rsc.niaid.nih.gov\/sites\/default\/files\/daidsgradingcorrectedv21.pdf (2017)."},{"key":"24433_CR44","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jaci.2003.07.003","volume":"112","author":"WT Shearer","year":"2003","unstructured":"Shearer, W. T. et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J. Allergy Clin. Immunol. 112, 973\u2013980 (2003).","journal-title":"J. Allergy Clin. Immunol."},{"key":"24433_CR45","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1365-2141.2004.05329.x","volume":"129","author":"C Dame","year":"2005","unstructured":"Dame, C. & Sutor, A. H. Primary and secondary thrombocytosis in childhood. Br. J. Haematol. 129, 165\u2013177 (2005).","journal-title":"Br. J. Haematol."},{"key":"24433_CR46","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3390\/ijerph13121236","volume":"13","author":"S Kim","year":"2016","unstructured":"Kim, S. Overview of cotinine cutoff values for smoking status classification. Int. J. Environ. Res. Public Health 13, 1236 (2016).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"24433_CR47","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.amepre.2017.03.020","volume":"53","author":"AL Merianos","year":"2017","unstructured":"Merianos, A. L., Jandarov, R. A. & Mahabee-Gittens, E. M. Secondhand smoke exposure and pediatric healthcare visits and hospitalizations. Am. J. Prev. Med. 53, 441\u2013448 (2017).","journal-title":"Am. J. Prev. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24433-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24433-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24433-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T11:08:42Z","timestamp":1668856122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24433-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["24433"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-24433-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2022,11,19]]},"assertion":[{"value":"24 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Marc TEBRUEGGE has received QuantiFERON assays at reduced pricing or free of charge for TB diagnostics projects from the manufacturer (Cellestis\/Qiagen) in the past, and has received support for conference attendance from Cepheid. The manufacturers had no influence on the study design, data collection, analysis or interpretation, writing of the manuscript or decision to submit the data for publication. The rest of authors have no conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19908"}}